The invention pertains to field of
organic chemistry,
medicine,
pharmacology, foods and
cosmetics industry, particularly, to
manufacturing technology of selenoxanthenes; the invention may be used in manufacturing of food supplements, pharmaceutical and cosmetic products, having bioactive properties, of a wide spectrum of activity. The proposed compound is the α-crystalline form of 9-phenyl-symmetrical-octahydroselenoxanthene with exhibits
antioxidant, detoxifying, immunomodulating, anti-atherogenic, anti-sclerotic, anabolic and hypolipidemic properties, and has the following
structural formula:Its
powder X-
ray diffractogram (obtained from a Cu-K X-
ray source) has characteristic diffractions in degrees of the
diffraction angle 2theta as 6.0, 12.0, 15.0, 17.0, 19.0, 20.0, 21.5, 21.7, 20.9, 25.0, 27.0, 28.0, 29.0, 37.0; the
melting point of 96.8° C. The crystalline form of the respective 9-R-symmetrical-selenoxantene product is obtained by
crystallization from a weakly polar or a non-polar
solvent.